Fogo AB - Search Results

1

International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology.

Nangaku M, Kitching AR, Boor P, Fornoni A, Floege J, Coates PT, Himmelfarb J, Lennon R, Anders HJ, Humphreys BD, Caskey FJ, Fogo AB; TRANSFORM group. Nangaku M, et al. Among authors: fogo ab. Kidney Int. 2023 Jul;104(1):36-45. doi: 10.1016/j.kint.2023.03.007. Epub 2023 Mar 28. Kidney Int. 2023. PMID: 37001557 Free article.

2

Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease.

Stokes MB, Holler S, Cui Y, Hudkins KL, Eitner F, Fogo A, Alpers CE. Stokes MB, et al. Kidney Int. 2000 Feb;57(2):487-98. doi: 10.1046/j.1523-1755.2000.00868.x. Kidney Int. 2000. PMID: 10652025 Free article.

3

COX2 activity promotes organic osmolyte accumulation and adaptation of renal medullary interstitial cells to hypertonic stress.

Moeckel GW, Zhang L, Fogo AB, Hao CM, Pozzi A, Breyer MD. Moeckel GW, et al. Among authors: fogo ab. J Biol Chem. 2003 May 23;278(21):19352-7. doi: 10.1074/jbc.M302209200. Epub 2003 Mar 9. J Biol Chem. 2003. PMID: 12637551 Free article.

4

Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats.

Ma LJ, Jha S, Ling H, Pozzi A, Ledbetter S, Fogo AB. Ma LJ, et al. Among authors: fogo ab. Kidney Int. 2004 Jan;65(1):106-15. doi: 10.1111/j.1523-1755.2004.00381.x. Kidney Int. 2004. PMID: 14675041 Free article.

5

Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury.

Chen X, Moeckel G, Morrow JD, Cosgrove D, Harris RC, Fogo AB, Zent R, Pozzi A. Chen X, et al. Among authors: fogo ab. Am J Pathol. 2004 Aug;165(2):617-30. doi: 10.1016/s0002-9440(10)63326-3. Am J Pathol. 2004. PMID: 15277235 Free PMC article.

6

Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.

Wang XP, Fogo AB, Colon S, Giannico G, Abul-Ezz SR, Miner JH, Borza DB. Wang XP, et al. Among authors: fogo ab. J Am Soc Nephrol. 2005 Dec;16(12):3563-71. doi: 10.1681/ASN.2005060670. Epub 2005 Oct 19. J Am Soc Nephrol. 2005. PMID: 16236801

7

Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth.

Liang XB, Ma LJ, Naito T, Wang Y, Madaio M, Zent R, Pozzi A, Fogo AB. Liang XB, et al. Among authors: fogo ab. J Am Soc Nephrol. 2006 Jul;17(7):1886-95. doi: 10.1681/ASN.2005020205. Epub 2006 Jun 21. J Am Soc Nephrol. 2006. PMID: 16790514

8

PPAR-gamma agonist protects podocytes from injury.

Kanjanabuch T, Ma LJ, Chen J, Pozzi A, Guan Y, Mundel P, Fogo AB. Kanjanabuch T, et al. Among authors: fogo ab. Kidney Int. 2007 Jun;71(12):1232-9. doi: 10.1038/sj.ki.5002248. Epub 2007 Apr 25. Kidney Int. 2007. PMID: 17457378 Free article.

9

Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group.

Joy MS, Gipson DS, Powell L, MacHardy J, Jennette JC, Vento S, Pan C, Savin V, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H. Joy MS, et al. Among authors: fogo ab. Am J Kidney Dis. 2010 Jan;55(1):50-60. doi: 10.1053/j.ajkd.2009.08.019. Epub 2009 Nov 22. Am J Kidney Dis. 2010. PMID: 19932542 Free PMC article. Clinical Trial.

10

Sirt1 activation protects the mouse renal medulla from oxidative injury.

He W, Wang Y, Zhang MZ, You L, Davis LS, Fan H, Yang HC, Fogo AB, Zent R, Harris RC, Breyer MD, Hao CM. He W, et al. Among authors: fogo ab. J Clin Invest. 2010 Apr;120(4):1056-68. doi: 10.1172/JCI41563. Epub 2010 Mar 24. J Clin Invest. 2010. PMID: 20335659 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

481 results

Search Page